HomeCompareFFVWF vs MRK

FFVWF vs MRK: Dividend Comparison 2026

FFVWF yields 666.67% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FFVWF wins by $608115.63M in total portfolio value
10 years
FFVWF
FFVWF
● Live price
666.67%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608115.66M
Annual income
$469,561,018,816.25
Full FFVWF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — FFVWF vs MRK

📍 FFVWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFFVWFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FFVWF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FFVWF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FFVWF
Annual income on $10K today (after 15% tax)
$56,666.67/yr
After 10yr DRIP, annual income (after tax)
$399,126,865,993.81/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, FFVWF beats the other by $399,126,865,186.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FFVWF + MRK for your $10,000?

FFVWF: 50%MRK: 50%
100% MRK50/50100% FFVWF
Portfolio after 10yr
$304057.84M
Annual income
$234,780,509,883.27/yr
Blended yield
77.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FFVWF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FFVWF buys
0
MRK buys
0
No recent congressional trades found for FFVWF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFFVWFMRK
Forward yield666.67%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$608115.66M$30.7K
Annual income after 10y$469,561,018,816.25$950.29
Total dividends collected$596792.85M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FFVWF vs MRK ($10,000, DRIP)

YearFFVWF PortfolioFFVWF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$77,367$66,666.67$11,192$351.54+$66.2KFFVWF
2$564,818$482,035.31$12,524$392.70+$552.3KFFVWF
3$3,893,246$3,288,890.67$14,015$438.65+$3.88MFFVWF
4$25,352,760$21,186,987.16$15,682$489.96+$25.34MFFVWF
5$156,070,781$128,943,327.59$17,547$547.23+$156.05MFFVWF
6$908,837,800$741,842,064.29$19,632$611.16+$908.82MFFVWF
7$5,009,769,782$4,037,313,336.56$21,963$682.53+$5009.75MFFVWF
8$26,159,339,258$20,798,885,591.56$24,571$762.18+$26159.31MFFVWF
9$129,490,317,125$101,499,824,118.87$27,486$851.08+$129490.29MFFVWF
10$608,115,658,140$469,561,018,816.25$30,745$950.29+$608115.63MFFVWF

FFVWF vs MRK: Complete Analysis 2026

FFVWFStock

FFVWF is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in FFVWF shares.

Full FFVWF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this FFVWF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FFVWF vs SCHDFFVWF vs JEPIFFVWF vs OFFVWF vs KOFFVWF vs MAINFFVWF vs JNJFFVWF vs ABBVFFVWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.